{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:17:49Z","timestamp":1697354269552},"reference-count":35,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1157\/13128726","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T12:56:19Z","timestamp":1227358579000},"page":"660-664","source":"Crossref","is-referenced-by-count":2,"title":["Hipertensi\u00f3n arterial, cardiopat\u00eda hipertensiva e insuficiencia card\u00edaca. Papel de los diur\u00e9ticos de asa"],"prefix":"10.1016","volume":"131","author":[{"given":"Manuel","family":"Anguita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1157\/13128726_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.HYP.13.5_Suppl.I74","article-title":"Changes in hypertension treatment and in congestive heart failure in the United States","volume":"13","author":"Yusuf","year":"1989","journal-title":"Hypertension"},{"key":"10.1157\/13128726_bb0010","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"10.1157\/13128726_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0002-9149(87)90466-8","article-title":"Population implications of electrocardiographic left ventricular hypertrophy","volume":"60","author":"Kannel","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1157\/13128726_bb0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-8703(94)90560-6","article-title":"Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension","volume":"127","author":"Ren","year":"1994","journal-title":"Am Heart J"},{"key":"10.1157\/13128726_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/euhj.1997.0839","article-title":"Clinical outcome with enalapril in symptomatic heart failure: a dose comparison","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1157\/13128726_bb0030","series-title":"Hypertension: pathophysiology, diagnosis and treatment","first-page":"253","article-title":"Public health issues in hypertension control: what has been learned from clinical trials","author":"Cutler","year":"1995"},{"key":"10.1157\/13128726_bb0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0735-1097(95)00606-0","article-title":"Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension tretment trials","volume":"27","author":"Moser","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1157\/13128726_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The CAPP randomised trail","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1157\/13128726_bb0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0300-8932(00)75177-3","article-title":"Insuficiencia card\u00edaca debida a disfunci\u00f3n ventricular sist\u00f3lica severa de origen hipertensivo. Evoluci\u00f3n cl\u00ednica y funcional a largo plazo","volume":"53","author":"Anguita","year":"2000","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13128726_bb0050","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0300-8932(04)77203-6","article-title":"Evoluci\u00f3n cl\u00ednica y reversibilidad de la disfunci\u00f3n sist\u00f3lica en pacientes con miocardiopat\u00eda dilatada hipertensiva e insuficiencia card\u00edaca cr\u00f3nica","volume":"57","author":"Anguita","year":"2004","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13128726_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0300-8932(01)76284-7","article-title":"Impacto de la hipertensi\u00f3n en las cardiopat\u00edas en Espa\u00f1a: estudio CARDIOTENS 1999","volume":"54","author":"Gonz\u00e1lez-Juanatey","year":"2001","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13128726_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/heart.88.3.249","article-title":"Clinical characteristics and prognosis of hospitalized inpatients with heart failure and preserved or reduced left ventricular ejection fraction","volume":"88","author":"Varela-Rom\u00e1n","year":"2002","journal-title":"Heart"},{"key":"10.1157\/13128726_bb0065","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0300-8932(03)77014-6","article-title":"Caracter\u00edsticas cl\u00ednicas y pron\u00f3stico a medio plazo de la insuficiencia card\u00edaca con funci\u00f3n sist\u00f3lica conservada. \u00bfEs diferente de la insuficiencia card\u00edaca sist\u00f3lica?","volume":"56","author":"Ojeda","year":"2003","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13128726_bb0070","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0300-8932(04)77258-9","article-title":"Caracter\u00edsticas cl\u00ednicas, tratamiento y morbimortalidad a corto y largo plazo de pacientes con insuficiencia card\u00edaca controlados en consultas espec\u00edficas de insuficiencia card\u00edaca. Resultados del Registro BADAPIC","volume":"57","author":"Anguita","year":"2004","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13128726_bb0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)80250-2","article-title":"Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy","volume":"99","author":"McDermott","year":"1995","journal-title":"Am J Med"},{"key":"10.1157\/13128726_bb0080","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic function and diastolic heart failure: part I. Diagnosis, prognosis and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1157\/13128726_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/hc3201.094226","article-title":"Heart failure with normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?","volume":"104","author":"Zile","year":"2001","journal-title":"Circulation"},{"key":"10.1157\/13128726_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardiores.2005.11.016","article-title":"Altered cardiac expression of peroxisome prolifierator activated receptor isoforms in patients with hypertensive heart disease","volume":"69","author":"Goicoechea","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1157\/13128726_bb0095","first-page":"48","article-title":"Annexin A5 is a marker of cardiomyocite apoptosis and systolic dysfunction in heart failure of hypertensive origin [resumen]","volume":"114","author":"Ravassa","year":"2006","journal-title":"Circulation"},{"key":"10.1157\/13128726_bb0100","first-page":"288","article-title":"Apoptosis and heart failure: clinical relevance and therapeutic target","volume":"21","author":"Garg","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1157\/13128726_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.coph.2005.01.004","article-title":"Targeting survival signaling in heart failure","volume":"5","author":"Morissette","year":"2005","journal-title":"Cur Opin Pharmacol"},{"key":"10.1157\/13128726_bb0110","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I syntesis in patients with heart failure of hypertensive origin. Relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13128726_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2006.01.077","article-title":"Alterations of the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure","volume":"48","author":"L\u00f3pez","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1157\/13128726_bb0120","first-page":"22F","article-title":"Papel del tratamiento antihipertensivo en la prevenci\u00f3n de la insuficiencia card\u00edaca","volume":"7","author":"Roig","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13128726_bb0125","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel versus diuretic","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13128726_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1053-2498(01)00776-8","volume":"21","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1157\/13128726_bb0135","series-title":"Manual de insuficiencia card\u00edaca","first-page":"123","article-title":"Esquema general del tratamiento de la insuficiencia card\u00edaca","author":"Anguita","year":"2003"},{"key":"10.1157\/13128726_bb0140","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","article-title":"Heart failure, chronic diuretic use and increase in mortality and hospitalization: an observational study using propensity score methods","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1157\/13128726_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1157\/13128726_bb0150","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"D\u00edez","year":"2002","journal-title":"Circulation"},{"key":"10.1157\/13128726_bb0155","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effect of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"L\u00f3pez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1157\/13128726_bb0160","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cos\u00edn","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1157\/13128726_bb0165","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"L\u00f3pez","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"Supl. 2","key":"10.1157\/13128726_bb0170","article-title":"Efecto de una nueva formulaci\u00f3n de torasemida (liberaci\u00f3n prolongada) sobre la fibrosis mioc\u00e1rdica en pacientes hipertensos con insuficiencia card\u00edaca","volume":"24","author":"D\u00edez","year":"2007","journal-title":"Hipertensi\u00f3n"},{"key":"10.1157\/13128726_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1527-3466.2008.00046.x","volume":"26","author":"Roca-Cusachs","year":"2008","journal-title":"Cardiovasc Ther"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775308754629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775308754629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T13:44:07Z","timestamp":1557927847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775308754629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":35,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0025775308754629"],"URL":"https:\/\/doi.org\/10.1157\/13128726","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}